Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
VLS-1488 by Volastra Therapeutics for Ovarian Cancer: Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase...
VLS-1488 by Volastra Therapeutics for Peritoneal Cancer: Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase...
VLS-1488 by Volastra Therapeutics for Fallopian Tube Cancer: Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Fallopian Tube Cancer. According to GlobalData,...